These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21688351)

  • 21. Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease.
    Malaty HM; Sansgiry S; Artinyan A; Hou JK
    Dig Dis Sci; 2016 Mar; 61(3):861-4. PubMed ID: 26514675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colectomy Rates for Ulcerative Colitis Differ between Ethnic Groups: Results from a 15-Year Nationwide Cohort Study.
    Misra R; Askari A; Faiz O; Arebi N
    Can J Gastroenterol Hepatol; 2016; 2016():8723949. PubMed ID: 28074174
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.
    Burisch J; Katsanos KH; Christodoulou DK; Barros L; Magro F; Pedersen N; Kjeldsen J; Vegh Z; Lakatos PL; Eriksson C; Halfvarson J; Fumery M; Gower-Rousseau C; Brinar M; Cukovic-Cavka S; Nikulina I; Belousova E; Myers S; Sebastian S; Kiudelis G; Kupcinskas L; Schwartz D; Odes S; Kaimakliotis IP; Valpiani D; D'Incà R; Salupere R; Chetcuti Zammit S; Ellul P; Duricova D; Bortlik M; Goldis A; Kievit HAL; Toca A; Turcan S; Midjord J; Nielsen KR; Andersen KW; Andersen V; Misra R; Arebi N; Oksanen P; Collin P; de Castro L; Hernandez V; Langholz E; Munkholm P;
    J Crohns Colitis; 2019 Feb; 13(2):198-208. PubMed ID: 30289522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
    Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
    J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.
    Safroneeva E; Vavricka SR; Fournier N; Straumann A; Rogler G; Schoepfer AM
    Inflamm Bowel Dis; 2015 Jun; 21(6):1348-58. PubMed ID: 25806845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Outcomes of Adalimumab Therapy in Korean Patients with Ulcerative Colitis: A Hospital-Based Cohort Study.
    Oh EH; Kim J; Ham N; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    Gut Liver; 2020 May; 14(3):347-356. PubMed ID: 31530738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
    Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
    Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.
    Manetti N; Bagnoli S; Rogai F; Bonanomi AG; Vannozzi G; Giannotta M; Annese V
    Inflamm Bowel Dis; 2016 Aug; 22(8):1945-53. PubMed ID: 27104823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
    Nguyen GC; Torres EA; Regueiro M; Bromfield G; Bitton A; Stempak J; Dassopoulos T; Schumm P; Gregory FJ; Griffiths AM; Hanauer SB; Hanson J; Harris ML; Kane SV; Orkwis HK; Lahaie R; Oliva-Hemker M; Pare P; Wild GE; Rioux JD; Yang H; Duerr RH; Cho JH; Steinhart AH; Brant SR; Silverberg MS
    Am J Gastroenterol; 2006 May; 101(5):1012-23. PubMed ID: 16696785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients Who Undergo Colectomy for Pediatric Ulcerative Colitis at Low-Volume Hospitals Have More Complications.
    Egberg MD; Galanko JA; Kappelman MD
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2713-2721.e4. PubMed ID: 30853617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.
    Oxford EC; Nguyen DD; Sauk J; Korzenik JR; Yajnik V; Friedman S; Ananthakrishnan AN
    Am J Gastroenterol; 2013 Jul; 108(7):1123-9. PubMed ID: 23419379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
    Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Jeuring SFG; Biemans VBC; van den Heuvel TRA; Zeegers MP; Hameeteman WH; Romberg-Camps MJL; Oostenbrug LE; Masclee AAM; Jonkers DMAE; Pierik MJ
    Am J Gastroenterol; 2018 Mar; 113(3):384-395. PubMed ID: 29317770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Colectomy Rates of Ulcerative Colitis over 40 Years of Different Therapeutic Eras-Results from a Western Hungarian Population-based Inception Cohort Between 1977 and 2020.
    Wetwittayakhlang P; Gonczi L; Lakatos L; Kurti Z; Golovics P; Pandur T; David G; Erdelyi Z; Szita I; Lakatos PL
    J Crohns Colitis; 2023 May; 17(5):712-721. PubMed ID: 36539328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort.
    Rodríguez C; Elosua A; Prieto C; Pérez E; Irisarri R; Campillo A; Rubio S; Nantes Ó; Angós R; Zozaya JM
    Gastroenterol Hepatol; 2022 Jan; 45(1):1-8. PubMed ID: 33545242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).
    Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Ekbom A; Rönnblom A
    J Crohns Colitis; 2013 Oct; 7(9):e351-7. PubMed ID: 23491313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Colectomy in Patients With Pediatric-onset Ulcerative Colitis.
    Rinawi F; Assa A; Eliakim R; Mozer-Glassberg Y; Nachmias-Friedler V; Niv Y; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):410-415. PubMed ID: 28207474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of race and ethnicity on perceptions of inflammatory bowel disease.
    Finlay DG; Basu D; Sellin JH
    Inflamm Bowel Dis; 2006 Jun; 12(6):503-7. PubMed ID: 16775495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.